ÂÜÀòÂÒÂ×

Jonathan Kafer currently serves as President of LumaCina and Chief Commercial Officer at Bridgewest Pharma since March 2023. Prior to this, Jonathan held the position of Executive Vice President and Chief Commercial Officer at Akorn Pharmaceuticals from April 2015 to March 2023. Jonathan's experience includes serving as Vice President of Account Management for US Managed Markets at Allergan, where responsibilities encompassed managing customer-facing account teams and developing channel strategies. Jonathan also held leadership roles in Sales and Marketing at Teva Pharmaceuticals, focusing on oncology products, and at Xanodyne Pharmaceuticals, overseeing Managed Markets and distribution strategies. Earlier experience includes roles at AAIPharma and Geneva Pharmaceuticals. Jonathan is an alumnus of The Ohio State University.